These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17711530)

  • 1. Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis.
    Takahashi MD; Castro LG; Romiti R
    Br J Dermatol; 2007 Oct; 157(4):828-31. PubMed ID: 17711530
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis.
    Heikkilä H; Ranki A; Cajanus S; Karvonen SL
    Arch Dermatol; 2005 Dec; 141(12):1607-10. PubMed ID: 16365275
    [No Abstract]   [Full Text] [Related]  

  • 3. Ustekinumab induces rapid clearing of erythrodermic psoriasis after failure of antitumour necrosis factor therapies.
    Santos-Juanes J; Coto-Segura P; Mas-Vidal A; Galache Osuna C
    Br J Dermatol; 2010 May; 162(5):1144-6. PubMed ID: 20222926
    [No Abstract]   [Full Text] [Related]  

  • 4. [Infliximab].
    Herrera E; Habicheyn S
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies.
    Castiñeiras I; Fernández-Diaz L; Juárez Y; Lueiro M
    J Dermatol; 2012 Aug; 39(8):730-1. PubMed ID: 22364316
    [No Abstract]   [Full Text] [Related]  

  • 6. Infliximab monotherapy in psoriasis: a case of rapid clinical and histological response.
    Vincek V; Jacob SE; Nassiri M; Herbert LM; Nadji M; Kerdel FA
    Int J Dermatol; 2004 Apr; 43(4):303-8. PubMed ID: 15090021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab (Remicade) for acute, severe pustular and erythrodermic psoriasis.
    Lisby S; Gniadecki R
    Acta Derm Venereol; 2004; 84(3):247-8. PubMed ID: 15202853
    [No Abstract]   [Full Text] [Related]  

  • 8. New development in the treatment of psoriasis--infliximab.
    Pietrzak A; Chodorowska G; Jazienicka I; Junak-Bojarska A; Roliński J
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):322-7. PubMed ID: 15315008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Up-date on the use of infliximab in dermatology. Introduction].
    Sánchez-Carazo J
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():1. PubMed ID: 19080984
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experience with infliximab in reclacitrant cases of psoriasis].
    Pereiro M; González-Vilas D; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():43-7. PubMed ID: 19080991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening pustular and erythrodermic psoriasis responding to infliximab.
    Lewis TG; Tuchinda C; Lim HW; Wong HK
    J Drugs Dermatol; 2006 Jun; 5(6):546-8. PubMed ID: 16774108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate.
    Warren RB; Brown BC; Carmichael AJ; Griffiths CE
    Clin Exp Dermatol; 2009 Apr; 34(3):415-6. PubMed ID: 19120390
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-alpha inhibitor infliximab.
    Jacobi A; Shuler G; Hertl M
    Br J Dermatol; 2005 Aug; 153(2):448-9. PubMed ID: 16086769
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of severe psoriasis with anti-TNF-alpha-antibody and methotrexate].
    Dalaker M; Bonesrønning JH
    Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1070-1. PubMed ID: 12760225
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
    Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
    Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression.
    Benoit S; Toksoy A; Bröcker EB; Gillitzer R; Goebeler M
    Br J Dermatol; 2004 May; 150(5):1009-12. PubMed ID: 15149518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment with a tumour necrosis factor antagonist and an oral retinoid: efficacy in severe acral psoriasis?
    Ingram JR; Anstey AV; Piguet V
    Br J Dermatol; 2012 Oct; 167(4):949-51. PubMed ID: 22486276
    [No Abstract]   [Full Text] [Related]  

  • 18. Consecutive use of different biological therapies in the treatment of psoriasis.
    Costanzo A; Papoutsaki M; Mazzotta A; Chimenti S
    Br J Dermatol; 2007 Aug; 157(2):394. PubMed ID: 17553044
    [No Abstract]   [Full Text] [Related]  

  • 19. Etanercept combined with methotrexate for high-need psoriasis.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurological symptoms following infusion of infliximab].
    Bebe AC; Harboe KM; Nøjgaard C
    Ugeskr Laeger; 2012 Oct; 174(40):2388-90. PubMed ID: 23031302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.